a:5:{s:8:"template";s:12592:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<title>{{ keyword }}</title>
<meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
<meta content="width=device-width,initial-scale=1.0" name="viewport"/>
<link href="http://fonts.googleapis.com/css?family=Yanone+Kaffeesatz:400,700" rel="stylesheet" type="text/css"/>
<link href="http://fonts.googleapis.com/css?family=Oswald" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css">@charset "utf-8";body,div,footer,form,h1,h2,h3,header,html,img,li,nav,p,span,time,ul{margin:0;padding:0;border:0;outline:0;font-size:100%;vertical-align:baseline;background:0 0}body{line-height:1}footer,header,nav{display:block}nav ul{list-style:none}a{margin:0;padding:0;font-size:100%;vertical-align:baseline;background:0 0}a{margin:0;padding:0;font-size:100%;vertical-align:baseline;background:0 0}input{vertical-align:middle}#sb-site,.sb-slidebar,body,html{margin:0;padding:0;-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}body,html{width:100%;overflow-x:hidden}html{height:100%}body{min-height:100%;height:auto;position:relative}#sb-site{width:100%;position:relative;z-index:1}.sb-slidebar{height:100%;overflow-y:auto;position:fixed;top:0;z-index:0;display:none;background-color:#fff;-webkit-transform:translate(0)}.sb-right{right:0}.sb-slidebar{width:30%}@media (max-width:480px){.sb-slidebar{width:70%}}@media (min-width:481px){.sb-slidebar{width:55%}}@media (min-width:768px){.sb-slidebar{width:40%}}@media (min-width:992px){.sb-slidebar{width:30%}}@media (min-width:1200px){.sb-slidebar{width:20%}}#sb-site,.sb-slidebar{-webkit-transition:-webkit-transform .4s ease;-moz-transition:-moz-transform .4s ease;-o-transition:-o-transform .4s ease;transition:transform .4s ease;-webkit-transition-property:-webkit-transform,left,right;-webkit-backface-visibility:hidden} @font-face{font-family:'Yanone Kaffeesatz';font-style:normal;font-weight:700;src:url(http://fonts.gstatic.com/s/yanonekaffeesatz/v14/3y9I6aknfjLm_3lMKjiMgmUUYBs04aUXNxt9gW2LIftoEdKZd2GP.ttf) format('truetype')}body{margin:0;font-family:'Century Gothic',Helvetica,Arial,Sans-serif;font-size:14px;line-height:20px;text-align:left;vertical-align:top;background:#fff;color:#000}body,form,h1,h2,h3,p{margin:0;padding:0}h1{font-size:24px;padding:0 0 10px 0}a:link,a:visited{text-decoration:none;color:#ef717d}a:hover{color:#f28b2e}p{padding:0 0 10px}.clear{clear:both}#sb-site{}#wrapper{background:#fff;margin:0 auto 0 auto;max-width:1000px;text-align:left;width:100%}#innerWrap{padding:0 30px;width:auto}#mainHd{min-height:163px;width:100%}#mainHd h1{float:left;height:163px;margin:0;text-indent:-9999px;width:234px}#mainHd h1 a{display:block;height:163px;width:234px}#mainHd .menu{border-top:6px double #999b9a;border-bottom:6px double #999b9a;float:right;font-family:'Yanone Kaffeesatz';font-size:44px;font-weight:700;line-height:44px;list-style:none;margin:25px 0 10px;padding:5px 0;max-width:706px;text-transform:uppercase;width:auto}#mainHd .menu li{float:left;list-style:none;position:relative}#mainHd .menu li a{padding:0 12px}#mainHd .menu li ul{display:none;position:absolute;top:44px;left:0;width:180px;background:#fff;box-shadow:0 0 4px #606060;z-index:99}#mainHd .menu li:hover ul{display:block}#mainHd .menu li ul li{float:none;font-size:24px;line-height:24px;margin:0;padding:0}#mainHd .menu li ul li a{display:block;padding:10px 0 10px 15px}#mainHd .menu li:nth-child(6n-5) a{color:#ef7163}#mainHd .menu li:nth-child(6n-5) a:hover{color:#999b9a}#mainHd .menu li:nth-child(6n-4) a,#mainHd .menu li:nth-child(6n-4) ul li a{color:#ef717d}#mainHd .menu li:nth-child(6n-4) a:hover,#mainHd .menu li:nth-child(6n-4) ul li a:hover{color:#999b9a}#mainHd .menu li:nth-child(6n-3) a{color:#f49081}#mainHd .menu li:nth-child(6n-3) a:hover{color:#999b9a}#mainHd .menu li:nth-child(6n-2) a{color:#f28b2e}#mainHd .menu li:nth-child(6n-2) a:hover{color:#999b9a}#mainHd .menu li:nth-child(6n-1) a{color:#fac829}#mainHd .menu li:nth-child(6n-1) a:hover{color:#999b9a}  .menu{border-top:1px solid #ccc;clear:both;font-family:'Yanone Kaffeesatz';font-size:30px;font-weight:700;line-height:30px;list-style:none;padding-top:5px;text-align:right;text-transform:uppercase}.sb-slidebar .menu li{border-bottom:1px solid #ccc;padding:0 0 5px;margin-bottom:5px}.sb-slidebar .menu ul{list-style:none;padding-top:5px}.sb-slidebar .menu ul li{border-bottom:none;font-size:24px;line-height:24px;padding:0 0 0;font-weight:400}.sb-slidebar .menu ul li a{color:#7bd3c7}.sb-slidebar .menu ul li a:hover{color:#5fbbb6}.sb-toggle-right{display:none;cursor:pointer;float:right;margin:0;padding-top:30px;width:25px}.sb-toggle-right .navicon-line{background:#ef717d;display:block;height:5px;margin:0 auto 5px;width:25px}.sb-toggle-right:hover .navicon-line{background:#5fbbb6}#mainFoot{background:#f49081;box-sizing:border-box;clear:both;color:#fff;padding:30px 2% 0 2%;width:100%}#leftFt{box-sizing:border-box;float:left;max-width:470px;padding-right:15px;width:50%}#leftFt #ftNav .menu{color:#fff;list-style:none;float:left;border-top:6px double #fff;border-bottom:6px double #fff;font-family:'Yanone Kaffeesatz';font-size:22px;font-weight:700;line-height:22px;padding:5px 0;margin-bottom:15px;text-transform:uppercase;width:100%}#leftFt #ftNav .menu li{float:left;padding:2px 5px 2px 0;border-right:3px solid #fff;margin-right:5px}#leftFt #ftNav .menu li:last-child{padding-right:0;border-right:none;margin-right:0}#leftFt #ftNav .menu li a{color:#fff}#leftFt #ftNav .menu li a:hover{color:#f8d4cf}#leftFt .socialIcons{color:#f8d4cf;font-family:'Yanone Kaffeesatz';font-size:28px;font-weight:700;line-height:28px;list-style:none;float:left;height:33px;text-transform:uppercase;vertical-align:bottom;width:410px}#leftFt .socialIcons::before{content:"DON'T BE ANTI-SOCIAL:"}#leftFt .socialIcons li a{background-position:center bottom;background-repeat:no-repeat;display:block;height:32px;width:32px}#leftFt .socialIcons li a:hover{background-position:center top}#rightFt{box-sizing:border-box;float:right;max-width:470px;padding-left:15px;width:50%}#rightFt::after{clear:both}#rightFt #bioPic{box-sizing:border-box;float:right;height:169px;margin:0 0 10px 15px;padding:5px;width:147px}#rightFt #bioPic img{height:auto;max-width:100%}#rightFt h3{color:#fff;font-family:havana;font-size:57px;font-weight:400;line-height:57px}#rightFt h3 span{color:#fac829}#mainFoot p{line-height:18px}p.copy{clear:both;color:#fff;font-size:10px;line-height:12px;margin:0;padding:10px 0 0}.copy a{color:#606060}.copy a:hover{color:#fff}#slider{margin-bottom:30px}#recBlog{background:#f7f5ef box-sizing:border-box;padding:20px 20px 40px;margin-bottom:20px;float:right;min-height:272px;width:74%}#recBlog h2{color:#ef717d;font-family:'Yanone Kaffeesatz';font-size:34px;font-weight:700;line-height:34px;margin:0 0 5px;padding:0;text-transform:uppercase;width:100%}#recBlog p.date{font-size:12px;line-height:16px}#recBlog .more{color:#fff;float:right;font-family:'Yanone Kaffeesatz';font-size:26px;font-weight:700;line-height:26px;text-transform:uppercase}#recBlog .more a{background:#ef717d;color:#fff;display:block;padding:5px 10px;width:auto}#recBlog .more a:hover{background:#f28b2e}#newsletter{background:#ef717d;box-sizing:border-box;color:#fff;float:left;margin-bottom:20px;padding:20px 20px 50px;width:24%}#newsletter h2{font-family:havana;font-size:48px;font-weight:400;line-height:48px;margin:0;padding:0}#newsletter h3{font-family:'Yanone Kaffeesatz';font-size:24px;line-height:24px;margin:0 0 15px;text-align:right;text-transform:uppercase}#newsletter input[type=email],#newsletter input[type=text]{background:#f799a2;border:none;box-sizing:border-box;height:32px;margin-bottom:10px;padding:5px 10px;width:100%}#newsletter input[type=submit]{background:#fac829;border:none;color:#fff;font-family:'Yanone Kaffeesatz';font-size:26px;font-weight:700;float:right;letter-spacing:normal;line-height:26px;padding:5px 10px;text-transform:uppercase;width:auto}#newsletter input[type=submit]:hover{background:#b1e2dc}#pco,#shco{box-sizing:border-box;float:left;padding-bottom:40px;width:50%}#pco{padding-right:10px}#pco h3{border-top:6px double #999b9a;border-bottom:6px double #999b9a;color:#f28b2e;font-family:'Yanone Kaffeesatz';font-family:havana;font-size:44px;font-weight:400;line-height:44px;margin:0 0 15px;padding:5px 0;text-align:center;width:100%}#shco{padding-left:10px}#shco h3{border-top:6px double #999b9a;border-bottom:6px double #999b9a;color:#5fbbb6;font-family:havana;font-size:44px;font-weight:400;line-height:44px;margin:0 0 15px;padding:5px 0;text-align:center;width:100%}.releaseBlock{box-sizing:border-box;max-width:320px;float:left;height:auto;margin:0;padding:10px;width:50%}.releaseBlock img{height:auto;max-width:100%}input[type=email]{background:#d8d8d8;border:none;box-sizing:border-box;height:40px;margin:0 0 15px;padding:10px 15px;width:100%}::-webkit-input-placeholder{color:#fff}:-moz-placeholder{color:#fff}::-moz-placeholder{color:#fff}:-ms-input-placeholder{color:#fff}.rslides{box-sizing:border-box;position:relative;list-style:none;width:100%;padding:0;margin:0;z-index:0}.rslides li{-webkit-backface-visibility:hidden;position:absolute;display:none;width:100%;left:0;top:0;z-index:0}.rslides li:first-child{position:relative;display:block;float:left}.rslides img{display:block;height:auto;float:left;width:100%;border:0}@media screen and (max-width:960px){#sb-site{background:#fff}#wrapper{padding:0;width:100%}#innerWrap{padding:0 5%;width:90%}#mainHd .menu{font-size:30px;line-height:30px}}@media screen and (max-width:865px){#mainHd{margin-bottom:20px}#mainHd h1{float:none;margin:0 auto}#mainHd .menu{float:left;font-size:44px;line-height:44px;margin:10px auto;max-width:100%;width:100%}#mainHd .menu li:last-child::after{clear:both}#mainHd .socialIcons{padding:0}}@media screen and (max-width:768px){#mainHd h1{float:left;margin:0}#mainHd #searchform,#mainHd .menu,#mainHd .socialIcons{display:none}.sb-toggle-right{display:block}#leftFt .socialIcons{display:none}#leftFt,#rightFt{float:none;margin:0 auto 20px;width:100%;max-width:100%}#newsletter,#recBlog{width:48%}#pco h3,#shco h3{font-size:30px;line-height:30px}.releaseBlock{float:none;margin:0 auto;width:100%}}@media screen and (max-width:480px){#newsletter,#recBlog{float:none;width:100%}#pco,#shco{float:none;padding:0 0 30px;width:100%}}@media only screen and (-webkit-min-device-pixel-ratio:2),only screen and (min--moz-device-pixel-ratio:2),only screen and (-o-min-device-pixel-ratio:2/1),only screen and (min-device-pixel-ratio:2){#mainHd h1{-webkit-background-size:234px 163px;-moz-background-size:234px 163px;-o-background-size:234px 163px;background-size:234px 163px} @font-face{font-family:Oswald;font-style:normal;font-weight:400;src:url(http://fonts.gstatic.com/s/oswald/v31/TK3_WkUHHAIjg75cFRf3bXL8LICs1_FvsUZiYA.ttf) format('truetype')}}</style>
</head>
<body>
<div id="sb-site">
<div id="wrapper">
<div id="innerWrap">
<header id="mainHd">
<h1>{{ keyword }}</h1>
<ul class="menu" id="menu-main-navigation-menu">
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-home menu-item-1995" id="menu-item-1995"><a href="#">{{ keyword }}</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page current_page_parent menu-item-1994" id="menu-item-1994"><a href="#">Blog</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-1998" id="menu-item-1998"><a href="#">About</a></li>
<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-1999" id="menu-item-1999"><a href="#">Tutorials</a></li>
</ul>
<div class="clear"></div>
</header>
{{ text }}
<p>.</p>
{{ links }}
</div>
<footer id="mainFoot">
<div id="leftFt">
<nav id="ftNav">
<ul class="menu" id="menu-footer-navigation-menu">
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2025" id="menu-item-2025"><a href="#">Terms of Use</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2015" id="menu-item-2015"><a href="#">Contact</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2027" id="menu-item-2027"><a href="#">Info</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2014" id="menu-item-2014"><a href="#">Additional Services</a></li>
</ul> </nav>
<div class="clear"></div>
<p class="copy">{{ keyword }}</p>
</div>
<div id="rightFt">
<div id="bioPic"></div>
<h3>{{ keyword }}</h3>
</div>
<div class="clear"></div>
</footer>
</div>
</div>
</body>
</html>";s:4:"text";s:9992:"<p>Venture capital GEN. GEN | News Highlights:Novartis Launches CRISPR Collaborations with Intellia, Caribou Caribou Biosciences. Caribou's technologies are based on research into the biology of CRISPR systems carried out by the Doudna Lab at the University of California, Berkeley, and their collaborators. Caribou co-founder and pioneering CRISPR/Cas9 researcher Jennifer Doudna has also joined as an investor, the … </p> <p>	Vice President </p> <p>For its agriculture biotech business, Caribou Biosciences has partnered with DuPont to cross-license key intellectual property, and collaborate on research. Novartis. </p> <p>	Vice President Our proprietary technology puts us at the forefront of the development of new medical therapies and bio-based products which offer profound benefits to both human health and society as a whole. </p> <p>Gene drives work to propel a gene of choice throughout a population and have been mooted as key to combatting pest-borne diseases like malaria, dengue fever, and Lyme disease too. 	Tel: 510-982-6030 | info@cariboubio.com Sep 22, 2014 </p> <p>Investors include Fidelity Biosciences, Novartis, Mission Bay Capital, 5 Prime Ventures, and an undisclosed strategic partner. </p> <p>Also participating in the round were existing investors, including F-Prime Capital Partners, Novartis, Mission Bay Capital, and 5 Prime Ventures. Caribou Biosciences is a operator of a medical technology company intended to analyze cell and genome engineering. Synthego Pioneers Next-Generation CRISPR Light Control Technology, Synthace Announces the Launch of New Product Helping Scientists Execute and Scale Key Assays, Atomwise Receives a $2.3M Grant to Develop New Therapies for Drug Resistant Malaria and Tuberculosis, Scribe Therapeutics to Collaborate With Biogen to Develop CRISPR-based Genetic Medicines for Neurological Diseases, Including Amyotrophic Lateral Sclerosis. Under the terms of the agreement, Caribou will receive funding for a one-year collaborative research program and Caribou will provide Novartis an option to non-exclusively license research use rights of the Caribou CRISPR-Cas9 platform. </p> <p>Illustrative of this approach, Caribou recently announced a collaboration agreement with Novartis Institutes for Biomedical Research under which the two companies will utilize Caribou's proprietary CRISPR-Cas9 platform to research new CRISPR-based drug target screening and validation technologies. </p> <p>	gregory.kelley@fkhealth.com, Caribou Biosciences, Inc. “The prospect of creating a radical new approach to accelerating trait development across crops and animals has positioned gene editing as one of the most revolutionary technologies in science. Investors include Fidelity Biosciences, Novartis, Mission Bay Capital, 5 Prime Ventures, and an undisclosed strategic partner. Under the terms of the agreement, Caribou will receive funding for a one-year collaborative research program and Caribou will provide Novartis an option to non-exclusively license research use rights of the Caribou CRISPR-Cas9 platform. 	Feinstein Kean Healthcare Get in touch on louisa@agfunder.com. Our proprietary technology puts us at the forefront of the development of new medical therapies and bio-based products which offer profound benefits to both human health and society as a whole. </p> <p>Caribou Biosciences has raised a total of $41M in funding across 2 rounds. Caribou Biosciences Raises $11M in Series A Funding. Companies People Investors Funding Rounds Acquisitions Schools Events Hubs Saved . </p> <p>Investors included Fidelity Biosciences, Novartis, Mission Bay Capital, 5 Prime Ventures, and one undisclosed partner. We see the same transformative potential in agriculture,” remarked Mr. Austin. Caribou Biosciences Raises $30 Million in Series B Funding. 	Feinstein Kean Healthcare This work was recently recognized by the award of a Breakthrough Prize to Caribou co-founder Jennifer Doudna, Investigator, Howard Hughes Medical Institute and Professor, U.C. Caribou also announced today that Philip Austin, Founding Partner at Anterra Capital, has joined the company’s Board of Directors, representing the Series B investor class. A mini guide to Latin American agrifoodtech in 2020, The biggest mistakes you can make when selling grain in volatile markets – and how to avoid them, Future Food ️: The future and sustainability of protein in our diets. Caribou's strategic focus is on building and deploying its CRISPR-Cas9 technology platform through relationships with industry leaders in multiple market sectors. Existing investors F-Prime Capital Partners, Novartis, Mission Bay Capital, and 5 Prime Ventures also joined the round. "CRISPR-Cas9 technology for gene editing is one of the most promising areas of scientific research today and Caribou, through its early work and its initial partnerships, has been a leader in this rapidly emerging field," remarked Robert Weisskoff, Ph.D., a partner at Fidelity Biosciences and newly appointed member of Caribou's Board of Directors. </p> <p>Greg Kelley SynBioBeta Town Hall on sequencing’s vital new role in fighting pandemics: A COVID-19 update from Illumina leadership, SynBioBeta State of the Industry Town Hall with Drew Endy, COVID-19 Town Hall with Nanome: Exploring the coronavirus spike protein in 3D virtual reality, SynBioBeta State of the Industry Town Hall with James Collins, SynBioBeta State of the Industry Town Hall with George Church, SynBioBeta COVID-19 Town Hall with JCVI’s Richard Scheuermann on coronavirus immune epitopes, COVID-19 Town Hall on Ginkgo’s $25M pledge and the community’s responses, COVID-19 Town Hall on environmental sampling for coronavirus. SynBioBeta is the leading community of innovators, investors, engineers, and thinkers who share a passion for using synthetic biology to build a better, more sustainable universe. Caribou Biosciences last raised $30M false. Caribou Biosciences is a developer of technology-based solutions for cellular engineering and analysis based on CRISPR-Cas9 biology. </p> <p>"We are thrilled to begin this collaboration with a recognized industry leader like Novartis and to gain access to its vast expertise in drug discovery," said Rachel Haurwitz, Ph.D., Chief Executive Officer and co-founder of Caribou Biosciences. NEW YORK (GenomeWeb) – Caribou Biosciences today announced that it has closed an $11 million Series A financing round. Operator of a medical technology company intended to analyze cell and genome engineering. </p> <p>Caribou Biosciences . This Startup Has A Solution For Both. </p> <p>Therefore, there is currently no regulation by the FDA, USDA, or European regulators for what are considered advanced breeding technologies and practices. Motif FoodWorks Thinks Yes. In addition, RNAi screens are also known to exhibit a high background, which can lead to both false negatives and the need for highly redundant libraries to ensure statistical significance. Another way to prevent getting this page in the future is to use Privacy Pass. Caribou Biosciences is a developer of technology-based solutions for cellular engineering and analysis based on CRISPR-Cas9 biology. The company specializes in cellular engineering and analysis based on the CRISPR-Cas9 technology platform which paired with a guide RNA, cuts double-stranded DNA and allows for specific changes to DNA, enabling development of therapeutics for agricultural biotechnology, … "We are delighted to have attracted such an impressive group of investors that share our enthusiasm for the vast potential of our proprietary CRISPR-Cas9-based cell engineering platform," said Rachel Haurwitz, Ph.D., Chief Executive Officer and co-founder of Caribou Biosciences. Caribou is advancing its CRISPR-Cas9 technology platform through relationships with companies in multiple market sectors. Caribou Biosciences’ current research is focused on refining the CRISPR technology to reduce these “off-target effects”, Doudna told NewYork Times journalist Jennifer Kahn late last year. We look forward to working with this outstanding group of investors, and bringing their deep expertise and guidance to bear as we deliver on the promise of our technology platform.”. Once the DNA strands are cut, the desirable genetic sequence can then be inserted or simply left to naturally repair itself. “We’ve been looking for an investment in gene editing applications for agriculture and decided that Caribou Biosciences was the industry leader,” Ben Belldegrun, managing partner at Pontifax AgTech, told AgFunderNews. Save Search . </p> <p>We’re dedicated to telling the stories of the people and companies involved, building their networks, and helping them grow. “Anterra was established to help transform the food sector by bringing cutting edge technologies into this industry. We develop technology-based solutions for cellular engineering and analysis based on the CRISPR-Cas9 technology platform. Anterra Capital’s Philip Austin will join Caribou’s board. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. </p> <p>Hosted Live and exclusively for our Bioeconomy Hub Members. Caribou Biosciences is developing the gene-editing technology for use across agriculture, therapeutics, biological research, and industrial biotechnology. In 2014, Caribou co-founded Intellia Therapeutics, which is utilizing Caribou's technology platform in the discovery, development and commercialization of human gene and cell therapies. Caribou's technologies are based on research into the biology of CRISPR-Cas systems carried out by the Doudna Lab at the University of California, Berkeley, and their collaborators. This work was recently recognized by the award of a Breakthrough Prize to Dr. Doudna and her collaborator Emmanuelle Charpentier, Helmholtz Center for Infection Research and Umeå University. Completing the CAPTCHA proves you are a human and gives you temporary access to the web property. </p>";s:7:"keyword";s:27:"caribou biosciences funding";s:5:"links";s:5902:"<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-mickey-virtue-wife'>Mickey Virtue Wife</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-lion-king-jr-they-live-in-you'>Lion King Jr They Live In You</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-cedar-valley-leadership-institute'>Cedar Valley Leadership Institute</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-cloud-street-cast'>Cloud Street Cast</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-commodore-hotel'>Commodore Hotel</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-2012-olympic-basketball-team-starters'>2012 Olympic Basketball Team Starters</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-uk-or-usa-which-is-better-for-education'>Uk Or Usa Which Is Better For Education</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-water-leak-tape'>Water Leak Tape</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-parks-and-rec-live-episode'>Parks And Rec Live Episode</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-is-canada-bigger-than-europe'>Is Canada Bigger Than Europe</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-plank-jacks-mountain-climbers'>Plank Jacks Mountain Climbers</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-up-down-push-ups-challenge'>Up Down Push Ups Challenge</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-barn-style-bar'>Barn Style Bar</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-up-and-down-plank-name'>Up And Down Plank Name</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-lea-tahuhu-instagram'>Lea Tahuhu Instagram</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-tsn-nba-scores'>Tsn Nba Scores</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-spain-vs-netherlands-final'>Spain Vs Netherlands Final</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-jfk-to-morocco-flight-time'>Jfk To Morocco Flight Time</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-ordeal-by-innocence-ending'>Ordeal By Innocence Ending</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-aria-restaurant-sydney-prices'>Aria Restaurant Sydney Prices</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-handbook-of-mathematical-economics'>Handbook Of Mathematical Economics</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-suburbs-in-durban-north'>Suburbs In Durban North</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-capital-of-italy'>Capital Of Italy</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-cake-order-online-hong-kong'>Cake Order Online Hong Kong</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-adventure-park-geelong-parking'>Adventure Park Geelong Parking</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-miraval-cost'>Miraval Cost</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-duke%27s-waikiki-happy-hour'>Duke's Waikiki Happy Hour</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-spain-vs-italy-euro-2012-group-stage'>Spain Vs Italy Euro 2012 Group Stage</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-merriam-webster-learners-dictionary'>Merriam-webster Learners Dictionary</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-kristen-wiig-snl-characters-gilly'>Kristen Wiig Snl Characters Gilly</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-david-sowden-obituary'>David Sowden Obituary</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-one-two%2C-buckle-my-shoe-barney'>One Two, Buckle My Shoe Barney</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-lord-and-taylor-northbrook-court'>Lord And Taylor Northbrook Court</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-fairy-wren-meaning'>Fairy-wren Meaning</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-drinking-water-suppliers-malta'>Drinking Water Suppliers Malta</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-future-of-work-research'>Future Of Work Research</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-cafe-bistro-pensacola-beach'>Cafe Bistro Pensacola Beach</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-landscape-restaurant-hobart%2C-tasmania'>Landscape Restaurant Hobart, Tasmania</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-link-nwwater'>Link Nwwater</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-thames-water-%28kemble%29-finance-plc'>Thames Water (kemble) Finance Plc</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-harvester-calories'>Harvester Calories</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-brunei-sultan'>Brunei Sultan</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-fernando-santos-net-worth'>Fernando Santos Net Worth</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-cactus-flower-hwy-98'>Cactus Flower Hwy 98</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-chocolate-protein-ice-cream'>Chocolate Protein Ice Cream</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-different-days-lyrics-nle-choppa'>Different Days Lyrics Nle Choppa</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-benefits-of-asean-economic-community'>Benefits Of Asean Economic Community</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-dubai-tap-water-hardness'>Dubai Tap Water Hardness</a>,
";s:7:"expired";i:-1;}